| Consensus guidelines for the use and interpretation of angiogenesis assays P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ... Angiogenesis 21, 425-532, 2018 | 607 | 2018 |
| Tumor microvessel density as a potential predictive marker for bevacizumab benefit: GOG-0218 biomarker analyses C Bais, B Mueller, MF Brady, RS Mannel, RA Burger, W Wei, KM Marien, ... JNCI: Journal of the National Cancer Institute 109 (11), djx066, 2017 | 99 | 2017 |
| Development and validation of a histological method to measure microvessel density in whole-slide images of cancer tissue KM Marien, V Croons, Y Waumans, E Sluydts, S De Schepper, L Andries, ... PLoS One 11 (9), e0161496, 2016 | 62 | 2016 |
| Tumor fusion burden as a hallmark of immune infiltration in prostate cancer MC Wagle, J Castillo, S Srinivasan, T Holcomb, KC Yuen, EE Kadel, ... Cancer immunology research 8 (7), 844-850, 2020 | 15 | 2020 |
| Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer T Muilwijk, M Akand, S Daelemans, K Marien, Y Waumans, M Kockx, ... PLoS One 16 (9), e0257195, 2021 | 14 | 2021 |
| NRG Oncology C Bais, B Mueller, MF Brady, RS Mannel, RA Burger, W Wei, KM Marien, ... Gynecologic Oncology Group. Tumor microvessel density as a potential …, 2017 | 12 | 2017 |
| Predictive tissue biomarkers for bevacizumab-containing therapy in metastatic colorectal cancer: an update KM Marien, V Croons, W Martinet, H De Loof, C Ung, W Waelput, ... Expert review of molecular diagnostics 15 (3), 399-414, 2015 | 11 | 2015 |
| The relationship between tumor-infiltrating lymphocytes, PD-L1 expression, driver mutations and clinical outcome parameters in non-small cell lung cancer adenocarcinoma in … S Mignon, K Willard-Gallo, G Van den Eynden, R Salgado, L Decoster, ... Pathology & Oncology Research 26, 1221-1228, 2020 | 10 | 2020 |
| The spatial localization of CD163+ tumor-associated macrophages predicts prognosis and response to therapy in inflammatory breast cancer. C Van Berckelaer, C Rypens, S Van Laere, K Marien, PJ Van Dam, ... Journal of Clinical Oncology 38 (15_suppl), 3086-3086, 2020 | 6 | 2020 |
| AutoTag and AutoSnap: Standardized, semi-automatic capture of regions of interest from whole slide images KM Marien, L Andries, S De Schepper, MM Kockx, GRY De Meyer MethodsX 2, 272-277, 2015 | 4 | 2015 |
| Van de VM, van Hinsbergh, Vermeulen VWM, Waltenberger PB, Weinstein J, Xin BM, Yetkin-Arik H, Yla-Herttuala B, Yoder S, Griffioen MC AW (2018) Consensus guidelines for the use … P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ... Angiogenesis 21 (3), 425-532, 0 | 4 | |
| P3. 02c-087 The Relationship of TILs and PD-L1 Expression in NSCLC Adenocarcinoma in Little to Non-Smokers with Driver Mutations and Outcome Parameters: Topic: IT Biomarkers S Mignon, K Willard-Gallo, G Van Den Eynden, R Salgado, W Waelput, ... Journal of Thoracic Oncology 12 (1), S1331, 2017 | 3 | 2017 |
| Abstract P5-04-04: the spatial interactions between FOXP3+ Tregs, CD8+ cytotoxic T cells and tumor cells predict response to therapy and prognosis in inflammatory breast cancer C Van Berckelaer, C Rypens, S Van Laere, K Marien, PJ van Dam, ... Cancer Research 80 (4_Supplement), P5-04-04-P5-04-04, 2020 | 1 | 2020 |
| 126 Development of a visual scoring method to determine inflamed, excluded or desert immune phenotype in non-small cell lung cancer, colorectal cancer, and urothelial cancer EL Ross, A Quarta, Y Waumans, P Lopez-Arias, K Avraam, Y Sillis, ... Journal for ImmunoTherapy of Cancer 12 (Suppl 2), 2024 | | 2024 |
| Fibroblast Activation Protein-α and the Immune Landscape: Unraveling T1 Non–muscle-invasive Bladder Cancer Progression T Muilwijk, L Baekelandt, M Akand, S Daelemans, K Marien, Y Waumans, ... European Urology Open Science 66, 67-74, 2024 | | 2024 |
| Progression of high-risk non-muscle invasive bladder cancer correlates with immune phenotypes and Fibroblast Activation Protein-α (FAP) T Muilwijk, L Baekelandt, M Akand, S Daelemans, K Marien, Y Waumans, ... European Urology 83, S612, 2023 | | 2023 |
| The spatial interactions between FOXP3+ Tregs, CD8+ cytotoxic T cells and tumor cells predict response to therapy and prognosis in inflammatory breast cancer C Van Berckelaer, C Rypens, S Van Laere, K Marien, PJ van Dam, ... Cancer Research 80 (4), 2020 | | 2020 |
| The spatial relations among immune cells are prognostic in inflammatory breast cancer C Van Berckelaer, CG Colpaert, C Rypens, K Marien, M Kockx, ... Annals of Oncology 30, iii11, 2019 | | 2019 |
| Abstract P4-06-08: The spatial localization of immune cells predicts prognosis and response to therapy in inflammatory breast cancer C Van Berckelaer, C Colpaert, C Rypens, KM Marien, Y Waumans, ... Cancer Research 79 (4_Supplement), P4-06-08-P4-06-08, 2019 | | 2019 |
| Immune cell profiling of melanoma metastases from patients treated with TriMixDC-MEL dendritic cell therapy in combination with ipilimumab. K Schats, EA Van Vre, I Debyser, A Vandenbroeck, Y Jansen, T Seremet, ... Journal of Clinical Oncology 35 (15_suppl), e21030-e21030, 2017 | | 2017 |
